MedTrace Logo

Comparative Study of Antimicrobial Effectiveness

NCT03817580 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2021-10-22

Study results available
· View outcomes & findings →

Summary

Comparative Study of Antimicrobial Effectiveness Evaluation of 26 ml Project X, 5.1ml Project X and Prevantics® Maxi Swabstick following ASTM E1173 - Standard Test Method for Evaluation of Preoperative, Precatheterization, or Preinjection Skin Preparations, ASTM International, West Conshohocken, PA, 2015,

Conditions

  • Bacterial Microflora Reduction

Interventions

DRUG

Project X 26ml

Application of antiseptic drug to the inguinal and abdomen areas of the subjects

DRUG

Project X 5.1ml

Application of antiseptic drug to the inguinal and abdomen areas of the subjects

DRUG

Prevantics Maxi Swabstick

Application of antiseptic drug to the inguinal and abdomen areas of the subjects

Sponsors & Collaborators

  • Professional Disposables International, Inc.

    lead INDUSTRY

Principal Investigators

  • Rozalia Olsavszky, MD · EUROFINS EVIC PRODUCT TESTING ROMANIA S.R.L

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-18
Primary Completion
2019-06-04
Completion
2019-06-04
FDA Drug
Yes

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03817580 on ClinicalTrials.gov